期刊文献+

临床药学工作开展情况与体会 被引量:4

Situation and experience of the work of clinical pharmacy
下载PDF
导出
摘要 目的:介绍江苏省盐城市第一人民医院临床药学工作开展情况与体会。方法:从参与查房与会诊、开展治疗药物监测与ADR监测工作、编辑药讯和定期参加病历检查等方面,叙述了临床药师具体的工作内容及对工作的思考、总结和体会。结果:本院临床药师深入临床,对临床合理用药起到了一定的促进作用。结论:临床药师应该加强学习,提高自身业务素质,积极深入临床,做好医师和护士的帮手,促进临床合理用药。临床药师只有在实践中不断磨练,提升技能,改变角色,才能满足社会对药师从保障供应型转变成参与临床用药的知识服务型的要求。 Objective: To introduce the situation and experience of the work of clinical pharmacy carried out by clinical pharmacists in the First People's Hospital of Yancheng City,Jiangsu Province. Methods: Through participating in rounds and consultation, monitoring therapeutic drugs, collecting adverse drug reaction (ADR), providing medicine information and inspecting medical documents regularly, the concrete work, the thinking and experience of clinical pharmacists are presented in this paper. Results: In the hospital, clinical pharmacists have played a certain role in clinical rational drug use. Conclusion: In order to promote rational drug use, clinical pharmacists should strengthen learning, improve their professional quality, and ac- tively participate in clinical treatment. Only through clinical practice (developing the skills and changing the role of pharma- cists), pharmacists can satisfy social requirements for them to change from guaranteeing supply into participating in clinical drug therapy and pharmaceutical care service.
作者 陈群 彭伟
出处 《药学服务与研究》 CAS CSCD 2009年第5期379-381,共3页 Pharmaceutical Care and Research
关键词 临床药学 药学服务 体会 clinical pharmacy pharmaceutical care experience
  • 相关文献

参考文献4

二级参考文献13

  • 1蔡威译.临床营养基础[M].上海:复旦大学出版社,2002.127-129.
  • 2黎介寿.肠外瘘[M].北京:人民军医出版社,2003.254-255.
  • 3王秀荣.临床营养医师速查手册[M].北京人民卫生出版社,2002.2-3
  • 4de-Gramont A, Figer A, Seymour M, et al. Leueovorin and fluorouraeil with or without oxaliplatin as first-line treatment in advanced eoloreetal cancer[ J ]. J Clin Oneol, 2000,18:2938-2947.
  • 5Extra J,Espie M,Calvo F,et al. Phase I study of oxaliplatin in patients with advanced cancer [ J ]. Cancer Chemother Pharmacol, 1990,25 : 299 -303.
  • 6Extra JM, Marty M, Brienza S, et al. Pharmacokinetics and safety profile of oxaliplatin [ J ]. Semin Oncol, 1998,25 : 13-22.
  • 7Andre T, Bensmaine MA, Louver C, et al. Muhicenter phase Ⅱ study of bimonthly high-dose leueovorin,fluorouracil infusion,and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen [ J ]. J Clin Oncol, 1999,17:3560-3568.
  • 8Murrie V, Gill J,Windebank A. Neurotoxic potential of platin compounds: role of cell cycle element [ J ]. Soc Neurosei,1998,24 : 1794.
  • 9徐孝麟.TPN的配制与稳定性[J].中国药房,2000,11(1):45-46. 被引量:29
  • 10翁海涌,翁海霞,颜海斌,叶荣飞.全静脉营养个体化配方[J].中国药事,2002,16(5):311-312. 被引量:10

共引文献39

同被引文献27

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部